Immuneering Corporation (IMRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
| Previous close | 1.3800 |
| Open | 1.3900 |
| Bid | 1.2900 x 200 |
| Ask | 1.3800 x 200 |
| Day's range | 1.3300 - 1.4100 |
| 52-week range | 1.3000 - 11.0600 |
| Volume | |
| Avg. volume | 365,956 |
| Market cap | 39.558M |
| Beta (5Y monthly) | -0.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We Think Immuneering (NASDAQ:IMRX) Needs To Drive Business Growth Carefully
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Simply Wall St.
Immuneering Director Acquires 7.5% More Stock
Potential Immuneering Corporation ( NASDAQ:IMRX ) shareholders may wish to note that the Director, Peter Feinberg...
- Zacks
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
Immuneering (IMRX) plunges after multiple Wall Street analysts downgraded the stock on lackluster results from an early-stage study evaluating its lead drug across advanced RAS-mutant solid tumors.
© 2024 Yahoo. All rights reserved.